Leerink Partnrs Forecasts Increased Earnings for Schrodinger

Schrodinger, Inc. (NASDAQ:SDGR) – Stock analysts at Leerink Partnrs increased their Q3 2025 EPS estimates for Schrodinger in a research report issued on Wednesday, August 6th. Leerink Partnrs analyst M. Foroohar now expects that the company will earn ($0.63) per share for the quarter, up from their previous estimate of ($0.69). The consensus estimate for Schrodinger’s current full-year earnings is ($2.37) per share. Leerink Partnrs also issued estimates for Schrodinger’s Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($2.16) EPS, FY2026 earnings at ($1.78) EPS, FY2027 earnings at ($1.97) EPS, FY2028 earnings at ($0.60) EPS and FY2029 earnings at ($0.99) EPS.

Several other equities analysts have also commented on the stock. KeyCorp decreased their price objective on shares of Schrodinger from $32.00 to $30.00 and set an “overweight” rating for the company in a research report on Monday, July 14th. Morgan Stanley initiated coverage on shares of Schrodinger in a report on Thursday, July 3rd. They issued an “equal weight” rating and a $28.00 price target on the stock.

Schrodinger Stock Down 3.0%

Shares of Schrodinger stock opened at $18.63 on Monday. The firm has a market capitalization of $1.37 billion, a P/E ratio of -7.51 and a beta of 1.67. The company has a 50 day moving average price of $21.49 and a 200 day moving average price of $22.46. Schrodinger has a 52 week low of $16.60 and a 52 week high of $28.47.

Schrodinger (NASDAQ:SDGR) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.24. The firm had revenue of $54.76 million during the quarter, compared to analyst estimates of $52.03 million. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. Schrodinger’s revenue was up 15.7% on a year-over-year basis. During the same period last year, the firm posted ($0.66) EPS.

Hedge Funds Weigh In On Schrodinger

Several hedge funds and other institutional investors have recently bought and sold shares of SDGR. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Schrodinger by 169.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,357,532 shares of the company’s stock worth $86,018,000 after buying an additional 2,737,728 shares during the period. American Century Companies Inc. acquired a new position in Schrodinger in the 1st quarter worth approximately $19,787,000. Stephens Investment Management Group LLC grew its stake in shares of Schrodinger by 22.5% during the 1st quarter. Stephens Investment Management Group LLC now owns 1,969,941 shares of the company’s stock worth $38,887,000 after purchasing an additional 362,285 shares during the period. Millennium Management LLC grew its stake in shares of Schrodinger by 42.3% during the 4th quarter. Millennium Management LLC now owns 761,653 shares of the company’s stock worth $14,692,000 after purchasing an additional 226,536 shares during the period. Finally, Jones Financial Companies Lllp grew its stake in shares of Schrodinger by 34,925.9% during the 1st quarter. Jones Financial Companies Lllp now owns 216,110 shares of the company’s stock worth $4,266,000 after purchasing an additional 215,493 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Schrodinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.